Feasibility of Dose Escalating [ 18F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer

AbstractPurposeThe aim of this study was to report the treatment planning feasibility of dose escalation to suspicious lymph nodes (LNs) for a series of men who underwent pretreatment [ 18F]fluciclovine positron emission tomography (PET)/magnetic resonance imaging (MRI). Methods and MaterialsCases o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advances in radiation oncology 2019-10, Vol.4 (4), p.649-658
Hauptverfasser: McDonald, Andrew M., MD, Galgano, Samuel J., MD, McConathy, Jonathan E., MD, Yang, Eddy S., MD, PhD, Dobelbower, Michael C., MD, PhD, Jacob, Rojymon, MD, Rais-Bahrami, Soroush, MD, Nix, Jeffrey W., MD, Popple, Richard A., MD, Fiveash, John B., MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:AbstractPurposeThe aim of this study was to report the treatment planning feasibility of dose escalation to suspicious lymph nodes (LNs) for a series of men who underwent pretreatment [ 18F]fluciclovine positron emission tomography (PET)/magnetic resonance imaging (MRI). Methods and MaterialsCases of men with prostate cancer who enrolled in a clinical trial of pretreatment [ 18F]fluciclovine PET who had suspicious LNs were selected. Pelvic LNs
ISSN:2452-1094
2452-1094
DOI:10.1016/j.adro.2019.05.008